Comparison of the 2019 European Alliance of Associations for Rheumatology/American College of Rheumatology Systemic Lupus Erythematosus Classification Criteria With Two Sets of Earlier Systemic Lupus Erythematosus Classification Criteria.


Journal

Arthritis care & research
ISSN: 2151-4658
Titre abrégé: Arthritis Care Res (Hoboken)
Pays: United States
ID NLM: 101518086

Informations de publication

Date de publication:
09 2021
Historique:
received: 09 01 2020
accepted: 12 05 2020
pubmed: 21 5 2020
medline: 6 10 2021
entrez: 21 5 2020
Statut: ppublish

Résumé

The Systemic Lupus International Collaborating Clinics (SLICC) 2012 systemic lupus erythematosus (SLE) classification criteria and the revised American College of Rheumatology (ACR) 1997 criteria are list based, counting each SLE manifestation equally. We derived a classification rule based on giving variable weights to the SLICC criteria and compared its performance to the revised ACR 1997, the unweighted SLICC 2012, and the newly reported European Alliance of Associations for Rheumatology (EULAR)/ACR 2019 criteria sets. The physician-rated patient scenarios used to develop the SLICC 2012 classification criteria were reemployed to devise a new weighted classification rule using multiple linear regression. The performance of the rule was evaluated on an independent set of expert-diagnosed patient scenarios and compared to the performance of the previously reported classification rules. The weighted SLICC criteria and the EULAR/ACR 2019 criteria had less sensitivity but better specificity compared to the list-based revised ACR 1997 and SLICC 2012 classification criteria. There were no statistically significant differences between any pair of rules with respect to overall agreement with the physician diagnosis. The 2 new weighted classification rules did not perform better than the existing list-based rules in terms of overall agreement on a data set originally generated to assess the SLICC criteria. Given the added complexity of summing weights, researchers may prefer the unweighted SLICC criteria. However, the performance of a classification rule will always depend on the populations from which the cases and non-cases are derived and whether the goal is to prioritize sensitivity or specificity.

Identifiants

pubmed: 32433832
doi: 10.1002/acr.24263
pmc: PMC10711744
mid: NIHMS1949336
doi:

Types de publication

Comparative Study Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1231-1235

Subventions

Organisme : NIAMS NIH HHS
ID : R01 AR069572
Pays : United States

Informations de copyright

© 2020, American College of Rheumatology.

Références

Arthritis Care Res (Hoboken). 2019 Jul;71(7):893-902
pubmed: 30044551
Ann Rheum Dis. 2018 Jun;77(6):911-913
pubmed: 29440000
Arthritis Rheumatol. 2019 Sep;71(9):1400-1412
pubmed: 31385462
Arthritis Rheum. 1997 Sep;40(9):1725
pubmed: 9324032
Arthritis Care Res (Hoboken). 2019 Nov;71(11):1404-1409
pubmed: 31058462
Arthritis Rheum. 1982 Nov;25(11):1271-7
pubmed: 7138600
Am J Nephrol. 2015;42(6):451-9
pubmed: 26812129
Clin Exp Rheumatol. 2014 May-Jun;32(3):440-4
pubmed: 24642380
Arthritis Rheum. 2012 Aug;64(8):2677-86
pubmed: 22553077
Arthritis Res Ther. 2015 Jan 10;17:3
pubmed: 25575961
Rheumatology (Oxford). 2015 Feb;54(2):241-7
pubmed: 25125590

Auteurs

Michelle Petri (M)

Johns Hopkins University, Baltimore, Maryland.

Daniel W Goldman (DW)

Johns Hopkins University, Baltimore, Maryland.

Graciela S Alarcón (GS)

University of Alabama at Birmingham.

Caroline Gordon (C)

University of Birmingham, Birmingham, UK.

Joan T Merrill (JT)

Oklahoma Medical Research Foundation, Oklahoma City.

Paul R Fortin (PR)

CHU de Québec - Université Laval, Quebec City, Quebec, Canada.

Ian N Bruce (IN)

The University of Manchester and Manchester University Hospital NHS Foundation Trust, Manchester Academic Health Science Center, Manchester, UK.

David Isenberg (D)

University College, London, UK.

Daniel Wallace (D)

Cedars-Sinai and University of California, Los Angeles.

Ola Nived (O)

Lund University, Lund, Sweden.

Rosalind Ramsey-Goldman (R)

Northwestern University, Chicago, Illinois.

Sang-Cheol Bae (SC)

Hanyang University Hospital for Rheumatic Diseases, Seoul, Republic of Korea.

John G Hanly (JG)

Queen Elizabeth II Health Sciences Centre and Dalhousie University, Halifax, Nova Scotia, Canada.

Jorge Sanchez-Guerrero (J)

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Ann E Clarke (AE)

University of Calgary, Calgary, Alberta, Canada.

Cynthia Aranow (C)

Feinstein Institute for Medical Research, Manhasset, New York.

Susan Manzi (S)

Allegheny Health Network, Pittsburgh, Pennsylvania.

Murray Urowitz (M)

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Dafna D Gladman (DD)

Centre for Prognosis Studies in the Rheumatic Diseases, Toronto Western Hospital and University of Toronto, Toronto, Ontario, Canada.

Ken Kalunian (K)

University of California at San Diego, La Jolla.

Victoria P Werth (VP)

Hospital of the University of Pennsylvania and Department of Veterans Affairs Medical Center, Philadelphia.

Asad Zoma (A)

Lanarkshire Centre for Rheumatology, Hairmyres Hospital, East Kilbride, Scotland, UK.

Sasha Bernatsky (S)

McGill University Health Centre, Montreal, Quebec, Canada.

Munther Khamashta (M)

The Rayne Institute, St Thomas' Hospital, King's College London, London, UK.

Søren Jacobsen (S)

Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.

Jill P Buyon (JP)

New York University, New York, New York.

Mary Anne Dooley (MA)

University of North Carolina, Chapel Hill.

Ronald van Vollenhoven (R)

Amsterdam University Medical Centres, University of Amsterdam, Free University, and Amsterdam Rheumatology and Immunology Center, Amsterdam, The Netherlands.

Ellen Ginzler (E)

State University of New York Downstate Medical Center, Brooklyn.

Thomas Stoll (T)

Kantonsspital, Schaffhausen, Switzerland.

Christine Peschken (C)

University of Manitoba, Winnipeg, Manitoba, Canada.

Joseph L Jorizzo (JL)

Wake Forest University, Winston-Salem, North Carolina, and Weill Cornell Medicine, New York, New York.

Jeffery P Callen (JP)

University of Louisville, Louisville, Kentucky.

Sam Lim (S)

Emory University, Atlanta, Georgia.

Murat Inanç (M)

Istanbul University, Istanbul, Turkey.

Diane L Kamen (DL)

Medical University of South Carolina, Charleston.

Anisur Rahman (A)

University College, London, UK.

Kristjan Steinsson (K)

Fossvogur Landspitali University Hospital, Reyjkavik, Iceland.

Andrew G Franks (AG)

New York University, New York, New York.

Laurence S Magder (LS)

University of Maryland, Baltimore.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH